Latest Board Governance News

AdNeo Limited has completed its acquisition of Learnt Global Group, secured $5.65 million through a placement, and significantly reduced its debt, marking a pivotal step in its growth strategy.

RBR Group Limited is strategically positioning itself to capitalise on the restart of major LNG projects in Mozambique, advancing joint ventures and raising capital to meet anticipated demand.

Bapcor reports a softer FY25 with pro-forma NPAT of $81-82 million and statutory NPAT sharply lower at $31-34 million, citing operational disruptions and a challenging retail environment. The company also announces key board resignations amid a strategic reset.

Universal Biosensors has signed a non-binding term sheet for an A$8.5 million senior secured loan with Viburnum Funds, alongside plans for an equity raising. The move comes with governance shifts, including a director resignation to avoid conflicts.

Southern Cross Media Group has finalized the sale of its remaining television assets, fully committing to its 'All About Audio' strategy with a 5% rise in audio revenues for FY25 and a renewed focus on debt reduction and dividends.

Epsilon Healthcare and its subsidiaries have officially exited voluntary administration and Deeds of Company Arrangement, marking a pivotal recovery milestone supported by significant personal commitments from the new board. The company now shifts focus to strategic growth and rebuilding trust.

Vulcan Steel announces a significant leadership transition with CEO Rhys Jones retiring after nearly two decades, handing the reins to Gavin Street from January 2026. The board reshuffle also sees Jones moving to non-executive Chair, ensuring continuity at the top.

Lovisa Holdings has appointed John Cheston as Global CEO and Managing Director, alongside Mark McInnes as Executive Deputy Chairman, signaling a strategic push for global growth.

Wingara AG Limited’s planned funding placement with Terra Firma Equity Limited has fallen through, prompting legal considerations and a pause on a key board appointment.

IVE Group Limited has scheduled its half-year financial results release for February 24, 2025, alongside a notable governance change with Paul Selig moving from Executive to Non-Executive Director.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.